Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy

OBJECTIVES: This study aimed to analyze a group of patients with severe and refractory antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) managed with rituximab and to report on treatment outcomes. PATIENTS AND METHODS: A total of 78 patients (41 females, 37 males; mean age: 50.1...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoneva, Tsvetelina, Zdravkova, Yana, Kotov, Georgi, Ivanova Todorova, Ekaterina, Vasilev, Georgi, Rashkov, Rasho, Sheytanov, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689016/
https://www.ncbi.nlm.nih.gov/pubmed/38046244
http://dx.doi.org/10.46497/ArchRheumatol.2023.9556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689016/
https://www.ncbi.nlm.nih.gov/pubmed/38046244
http://dx.doi.org/10.46497/ArchRheumatol.2023.9556

Ejemplares similares